Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Capital Employed: 2019-2025

Historic Return on Capital Employed for Arcturus Therapeutics Holdings (ARCT) over the last 6 years, with Sep 2025 value amounting to -0.30%.

  • Arcturus Therapeutics Holdings' Return on Capital Employed fell 4.00% to -0.30% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.30%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of -0.30% for FY2024, which is 8.00% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Return on Capital Employed stood at -0.30% for Q3 2025, which was down 12.01% from -0.26% recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' Return on Capital Employed's 5-year high stood at 0.21% during Q1 2023, with a 5-year trough of -0.75% in Q1 2022.
  • Its 3-year average for Return on Capital Employed is -0.17%, with a median of -0.26% in 2025.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 96bps in 2023, then plummeted by 61bps in 2024.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Return on Capital Employed (Quarterly) stood at -0.65% in 2021, then skyrocketed by 70bps to 0.05% in 2022, then dropped by 27bps to -0.22% in 2023, then fell by 11bps to -0.33% in 2024, then dropped by 4bps to -0.30% in 2025.
  • Its Return on Capital Employed was -0.30% in Q3 2025, compared to -0.26% in Q2 2025 and -0.28% in Q1 2025.